Clearstead Advisors LLC Buys 6,341 Shares of Danaher Corporation $DHR

Clearstead Advisors LLC lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 6.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 100,280 shares of the conglomerate’s stock after acquiring an additional 6,341 shares during the period. Clearstead Advisors LLC’s holdings in Danaher were worth $22,956,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. JPL Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter worth about $26,000. WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter worth about $26,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher during the 3rd quarter worth about $27,000. Finally, Financial Life Planners bought a new position in Danaher in the 3rd quarter valued at about $32,000. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.1%

NYSE:DHR opened at $172.12 on Monday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The firm has a market cap of $121.82 billion, a price-to-earnings ratio of 33.29, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm has a 50-day moving average price of $183.52 and a two-hundred day moving average price of $208.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the business posted $1.88 EPS. On average, equities analysts expect that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is 30.95%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on DHR shares. Guggenheim dropped their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. TD Cowen dropped their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Morgan Stanley dropped their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, Argus dropped their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Nineteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $238.65.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.